1.Research progress of Acanthopanax senticosus in prevention and treatment of neurodegenerative diseases.
Xue WANG ; Zhao DAI ; Jian-Song FANG
China Journal of Chinese Materia Medica 2022;47(16):4314-4321
Neurodegenerative diseases are global public health problems that seriously affect the quality of human life. The incidence of neurodegenerative diseases is increasing year by year and there has been no effective treatment. Acanthopanax senticosus is a Chinese medicine for tonifying kidney and has a long medicinal and edible history. It contains many active ingredients such as saponins, coumarins, flavonoids, organic acids and polysaccharides, with pharmacological effects of anti-oxidation, anti-age, anti-inflammation, anti-fatigue and immune regulation. Modern medical studies have found that A. senticosus can act on the central nervous system, and its extracts and active ingredients can improve learning and memory ability, playing vital roles of anti-oxidation, anti-inflammation, anti-apoptosis, antagonizing against amyloid β protein(Aβ) toxicity, modulating neurotransmitter release, signaling pathways and brain energy metabolism, maintaining the structure and function of mitochondria, and epigenetic regulation. It treats neurodegenerative diseases via multiple components, multiple targets, and multiple pathways, with the characteristics of low toxic side effects. This study reviewed the pharmacological reports of A. senticosus on neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease and ischemic stroke in China and abroad in recent ten years, and summarized the active ingredients and the mechanism underlying the neuroprotective effects of A. senticosus. Additionally, the significant advantages of A. senticosus in the treatment of neurodegenerative diseases and the limitations of the reports were discussed from the aspects of traditional Chinese medicine(TCM) theory and modern medical research. This study provided theoretical support for the drug development and clinical application of A. senticosus in treating neurodegenerative diseases and also facilitated the prevention and treatment of neurodegenerative diseases by kidney-tonifying method in TCM.
Amyloid beta-Peptides
;
Anti-Inflammatory Agents
;
Eleutherococcus/chemistry*
;
Epigenesis, Genetic
;
Humans
;
Neurodegenerative Diseases/prevention & control*
;
Plant Extracts/therapeutic use*
2.Effects of Carpobrotus edulis Extract on Oxidative Stress and 158N Oligodendrocyte Death.
Amira ZARROUK ; Mohammed Ali SMACH ; Jawhar HAFSA ; Randa SGHAIER ; Hatem MAJDOUB ; Mohammed HAMMAMI ; Bassem CHARFEDDINE
Biomedical and Environmental Sciences 2019;32(4):291-299
OBJECTIVE:
Age-related diseases, including neurodegenerative diseases, are associated with oxidative stress and lipid peroxidation, and increase the levels of cholesterol auto-oxidation products such as 7β-hydroxycholesterol (7β-OHC). Thus, it is imperative to identify agents that can prevent 7β-OHC-induced side-effects.
METHODS:
We evaluated the potential protective effects of Carpobrotus edulis ethanol-water extract (EWe) on murine oligodendrocytes (158N) cultured in the absence or presence of 7β-OHC (20 μg/mL, 24 h). The cells were incubated with EWe (20-200 µg/mL) 2 h before 7β-OHC treatment. Mitochondrial activity and cell growth were evaluated with the MTT assay. Photometric methods were used to analyze antioxidant enzyme [catalase (CAT) and glutathione peroxidase (GPx)] activities and the generation of lipid and protein oxidation products [malondialdehyde (MDA), conjugated diene (CD), and carbonylated proteins (CPs)].
RESULTS:
Treatment with 7β-OHC induced cell death and oxidative stress (reflected by alteration in CAT and SOD activities). Overproduction of lipid peroxidation products (MDA and CDs) and CPs was also reported. The cytotoxic effects associated with 7β-OHC were attenuated by 160 μg/mL of EWe of C. edulis. Cell death induced by 7β-OHC treatment was ameliorated, GPx and CAT activities were restored to normal, and MDA, CD, and CP levels were reduced following C. edulis extract treatment.
CONCLUSION
These data demonstrate the protective activities of C. edulis EWe against 7β-OHC-induced disequilibrium in the redox status of 158N cells, indicative of the potential role of this plant extract in the prevention of neurodegenerative diseases.
Aizoaceae
;
Animals
;
Cell Line
;
Drug Evaluation, Preclinical
;
Hydroxycholesterols
;
Mice
;
Neurodegenerative Diseases
;
prevention & control
;
Neuroprotection
;
Oligodendroglia
;
drug effects
;
metabolism
;
Oxidative Stress
;
drug effects
;
Phytotherapy
;
Plant Extracts
;
pharmacology
;
therapeutic use
4.Neural stem cells: mechanisms and modeling.
Jun YAO ; Yangling MU ; Fred H GAGE
Protein & Cell 2012;3(4):251-261
In the adult brain, neural stem cells have been found in two major niches: the dentate gyrus and the subventricular zone [corrected]. Neurons derived from these stem cells contribute to learning, memory, and the autonomous repair of the brain under pathological conditions. Hence, the physiology of adult neural stem cells has become a significant component of research on synaptic plasticity and neuronal disorders. In addition, the recently developed induced pluripotent stem cell technique provides a powerful tool for researchers engaged in the pathological and pharmacological study of neuronal disorders. In this review, we briefly summarize the research progress in neural stem cells in the adult brain and in the neuropathological application of the induced pluripotent stem cell technique.
Hippocampus
;
cytology
;
metabolism
;
Humans
;
Induced Pluripotent Stem Cells
;
cytology
;
metabolism
;
Models, Biological
;
Neural Stem Cells
;
cytology
;
metabolism
;
transplantation
;
Neurodegenerative Diseases
;
metabolism
;
pathology
;
prevention & control
;
Neurogenesis
;
Signal Transduction
5.Advances in the study of immunopharmacological effects and mechanisms of extracts of Tripterygium wilfordii Hook. f. in neuroimmunologic disorders.
Xiao-dong PAN ; Xiao-chun CHEN
Acta Pharmaceutica Sinica 2008;43(12):1179-1185
Extracts of Chinese herb Tripterygium wilfordii Hook. f. (TWHF) have been found to have potent anti-inflammatory and immunosuppressive functions and widely used in China for treatment of rheumatoid arthritis. Also they have been considered to be the potential drugs in the treatment of tumor and acute graft rejections. With the progress of neuroimmunological research on neurodegenerative diseases, such as Alzheimer's disease (AD), Parkinson disease (PD) and multiple sclerosis (MS), the neuroprotective strategies to rescue neurons from immunological injury are currently being explored. Recently, studies have indicated that extracts of TWHF such as triptolide, tripchlorolide and (5R)-5-hydroxytriptolide are able to attenuate progression of these neuroimmunologic disorders in vitro and in vivo. Accumulating evidence has shown that they can promote neuronal survival and neurite growth and facilitate functional recovery of brain injury by invoking distinct mechanisms that are related to their neuroprotective roles as inhibitor of neuroinflammatory toxicity of activated-microglia, antioxidants, calcium channel blockers, neurotrophic actions, modulating T cell functions, inhibitor of transcriptional activation of NF-kappaB on genes and signaling. Significant pharmaceutical strategies against neuroimmunologic disorders will hopefully be discovered by understanding the valuable components of TWHF.
Animals
;
Anti-Inflammatory Agents
;
pharmacology
;
Antioxidants
;
pharmacology
;
Diterpenes
;
isolation & purification
;
pharmacology
;
therapeutic use
;
Drugs, Chinese Herbal
;
isolation & purification
;
pharmacology
;
therapeutic use
;
Epoxy Compounds
;
isolation & purification
;
pharmacology
;
therapeutic use
;
Humans
;
NF-kappa B
;
metabolism
;
Neurodegenerative Diseases
;
drug therapy
;
prevention & control
;
Phenanthrenes
;
isolation & purification
;
pharmacology
;
therapeutic use
;
Structure-Activity Relationship
;
Tripterygium
;
chemistry
6.FK506-binding proteins and neurodegenerative diseases.
Li-qin ZHAO ; Jun-hai XIAO ; Wei HUANG ; Song LI
Acta Pharmaceutica Sinica 2002;37(9):743-748
Animals
;
Brain
;
metabolism
;
Humans
;
Nerve Regeneration
;
drug effects
;
Neurodegenerative Diseases
;
metabolism
;
prevention & control
;
Neuroprotective Agents
;
metabolism
;
therapeutic use
;
Tacrolimus Binding Protein 1A
;
metabolism
;
Tacrolimus Binding Proteins
;
metabolism
;
therapeutic use

Result Analysis
Print
Save
E-mail